Search bioRxiv⌕ Search

bioRxiv · 10.1101/2021.09.01.458500

Network topology and evolution of the gene co-expression of T-cells during immuno-senescence

Abstract

To better understand the potential impact of the gene expression network structure on the dynamics of immune-senescence and defects of cell functions during aging, we investigated network structures in both young and old individuals. We analyzed the gene co-expression networks (GCNs) derived from an aging signature of 130 immune-related genes obtained from CD3+ T-cell splenocytes extracted from FVB/N, C57BL/6N, and BALB/c mice at ages 2 and 22- 24 months. The network structure for the two different mouse age-groups was derived and subsequently analyzed. Analysis of network hubs using clustering coefficients, degree, betweenness, eigenvector, and closeness centralities, as well as local, indirect, and total influence measures, demonstrated changes in gene behavior and network control between the two age groups. Our quantification shows that the young, 2-month old mouse network is more organized than the 22-24-month, old mouse network, while the network structure of the older mouse GCN appears to be far more complicated but far more dispersed. Changes in network structure between the old and young mice suggest deterioration in transcription regulation with age in peripheral T- cells, particularly within the TCR signaling pathway, and potential compensatory mechanisms in older T-cells to overcome loss to regular function resulting from transcriptional irregularity. These results demonstrate the need for more research into gene co-expression in peripheral T-cells in order to better understand both network irregularities and the phenotypic dysfunction observed in older individuals. Author SummaryIn order to better understand the potential mechanisms of transcriptional irregularities in the immune system with aging, we analyzed the structure of gene co-expression networks of T-cells extracted from the spleens of 2 and 22-24-month old mice. Gene co-expression describes the correlation relationship between two expressed genes; as the expression of one gene goes up, the expression of another gene might also increase (or, conversely, decrease). Strong gene co- expression relationships can signal the existence of a number of important biological phenomena, such as two genes belonging to a transcription pathway or protein structure. Network diagrams visualizing these co-expression relationships in both younger and older mice demonstrated the existence of differences in network structure and properties that may be attributed to the aging of the immune system. Network mathematical methods were used to examine the complexity of each network. We found that the younger mouse network was more organized than the older mouse network. The older mouse group exhibited a 255% increase in co-expression relationships but a decrease of 92% of the connections from the young mouse network. This suggests the older mouse T-cells suffer dysfunction at a transcriptional level. This results in the loss of regular immune and cellular functions. These results demonstrate the importance of future research into gene co-expression to decipher senescence or diseases that perturb gene expression through time.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Witten, T. M., Mair, M. L., Tchitcheck, N., Thomas-Vaslin, V.. 2021-09-02. Network topology and evolution of the gene co-expression of T-cells during immuno-senescence. https://doi.org/10.1101/2021.09.01.458500

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

INFORME: coupling information-theoretic experimental design with nonlinear mixed-effects modeling for efficient observation scheduling

Mathematical models of treatment response can inform individualized therapy, but their calibration often requires longitudinal measurements that are costly, burdensome, and collected on fixed schedules. Such schedules may be inefficient, over-sampling patients whose response is already well characterized while delaying informative measurements for those whose model parameters remain uncertain. We present INFORME (INFORmation-theoretic design with Mixed Effects), a framework that combines Bayesian information-theoretic experimental design with nonlinear mixed-effects modeling to adaptively select each patients next measurement time. Population and response-subgroup parameter distributions learned from an existing cohort provide informative priors, allowing candidate measurement times to be ranked by their expected reduction in patient-specific parameter uncertainty. As observations accumulate, priors can be updated to reflect the response subgroup most consistent with the patients data. We evaluate INFORME in two radiotherapy datasets: 150 synthetic tumor volume trajectories from a hybrid cellular automaton model of prostate cancer spheroids (HD1) and longitudinal tumor volumes from 39 patients with head-and-neck cancer (HD2). In HD1, population priors allowed omission of both pretreatment scans, while adaptive scheduling reduced the protocol from nine scans to three or four, with the response group identified from a single post-treatment scan on day 27. In HD2, the adaptive schedule used three scans instead of six and improved prediction by delaying the first on-treatment scan from week 1 to week 2, avoiding transient dynamics that produced false-positive and false-negative response projections. Across both datasets, the adaptive schedules used a mean of 2.7 scans in stead of seven and advanced completion of the patient-specific prediction by a mean of 15.5 days (95% CI, 6.7-24.3) relative to the equidistant protocol, while treatment duration remained unchanged. INFORME therefore reduces measurement burden and accelerates patient-specific prediction by concentrating observations at times that are most informative for model calibration.

systems biology↗

Sobetirome, a thyroid hormone receptor beta agonist, is a potential therapeutic agent for pulmonary fibrosis

Idiopathic pulmonary fibrosis (IPF) is a progressive and fatal disease with limited treatment options. Our group previously identified the antifibrotic potential of thyroid hormone, triiodothyronine (T3); however, clinical translation of thyroid hormone therapy is limited by its systemic adverse effects. In this study, we investigate whether sobetirome, a selective and well tolerated thyroid hormone receptor beta (THRB) agonist, offers antifibrotic benefits of thyroid hormone while minimizing systemic toxicity. Our study reveals that sobetirome, administered via intraperitoneal or inhalational routes, effectively mitigates bleomycin-induced pulmonary fibrosis in mice, with no evidence of toxicity. We identified that sobetirome restores mitochondrial homeostasis via activating the THRB-PPARGC1a axis. This protects alveolar type II epithelial cells from injury-induced apoptosis while selectively inducing apoptosis and metabolic reprogramming in apoptosis resistant IPF fibroblasts. Cell-specific deletion of Ppargc1a in either alveolar epithelial cells or fibroblasts abolishes sobetirome-mediated protection, establishing PPARGC1a as an essential mediator of therapeutic response. Importantly, sobetirome reverses fibrosis-associated transcriptional programs in human IPF lung tissue, reducing expression of key fibrosis-associated genes, including collagen I alpha 1 (COL1A1), collagen III alpha 1 (COL3A1), periostin (POSTN), cathepsin K (CTSK), and Chitinase 3 Like 1 (CHI3L1), while promoting extracellular matrix remodeling, epithelial restoration, and tissue homeostasis. Collectively, our findings identify THRB activation as a novel metabolic strategy for reversing pulmonary fibrosis. Across complementary in vitro, in vivo, and human ex vivo models, sobetirome restores mitochondrial function, modulates apoptotic pathways in pathogenic cells, and promotes fibrosis resolution, highlighting its potential as a lung-targeted therapeutic approach for IPF and other fibrotic lung diseases.

systems biology↗

Mechanistic modeling of bacterial translation initiation across growth conditions

Translation frequency in bacteria depends on how ribosomes, mRNAs, and initiation factors are allocated across growth conditions. Here, we developed a mechanistic ODE-based model of Escherichia coli translation that represents initiation, elongation, termination, and coupled auxiliary processes. Growth-dependent abundances were derived from physiological relationships and reprocessed omics data, and simulated outputs were compared with translation-frequency and active-ribosome references. The model predicts a continuous shift from complex-formation-limited toward ribosome-limited behavior as growth increases. This shift is characterized by a decline in free-ribosome abundance, whereas initiation-factor pools remain largely unbound and do not become depleted in parallel. Together with the implemented IF-dependent kinetic term, this preserved availability provides a model-internal route through which productive initiation can be maintained despite increasing ribosome utilization. Consistently, transcript-wide ribosome loading remains below its theoretical maximum, while COG-level simulations reveal distinct sector-specific translation-frequency trajectories. The study therefore provides a resource-allocation framework for interpreting how mRNA--ribosome interactions shape bacterial translation across growth conditions.

systems biology↗